Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
304 studies found for:    Open Studies | "Stomach Diseases"
Show Display Options
Rank Status Study
21 Recruiting Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial
Condition: Functional Dyspepsia
Intervention: Device: Acupuncture
22 Unknown  SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
Condition: Dumping Syndrome
Interventions: Drug: Lanreotide 90 mg slow release formulation;   Drug: Placebo
23 Recruiting Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Intervention: Drug: Dovitinib
24 Recruiting Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Cabazitaxel
25 Recruiting Haloperidol vs Conventional Therapy for Gastroparesis
Condition: Gastroparesis
Intervention: Drug: Haloperidol
26 Unknown  Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
Condition: Gastric Cancer
Intervention: Drug: CAPECITABINE
27 Recruiting S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: Cisplatin;   Drug: Oxaliplatin
28 Recruiting FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Pazopanib;   Drug: 5-FU, Oxaliplatin, Leukovorin (FLO)
29 Recruiting Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer
Condition: Gastric Cancer
Intervention: Biological: OTSGC-A24
30 Not yet recruiting Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia
Condition: Functional Dyspepsia
Intervention: Drug: Acthrel
31 Unknown  S-1-induced Lacrimal Drainage Obstruction
Condition: Gastric Cancer
Intervention: Drug: S-1
32 Recruiting Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Condition: Dumping Syndrome Patients
Intervention: Drug: SOM230
33 Unknown  The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM)
Condition: Gastric Intestinal Metaplasia
Intervention:
34 Unknown  Open vs Laparoscopic Pyloromyotomy for Pyloric Stenosis
Condition: Pyloric Stenosis
Intervention: Procedure: pyloromyotomy
35 Recruiting Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: XELOX;   Drug: XELODA
36 Recruiting Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study
Condition: Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer
Intervention: Procedure: gastrectomy
37 Recruiting YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome
Condition: Carcinoid
Intervention: Drug: YF476
38 Not yet recruiting A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection
Condition: Gastric Cancer
Intervention: Procedure: reduced port laparoscopic distal gastrectomy
39 Recruiting Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer
Condition: Metastatic Gastric Cancer
Interventions: Drug: folinic acid+fluorouracil+oxaliplatin;   Drug: Capecitabine
40 Recruiting 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
Condition: Gastroenteropancreatic Neuroendocrine Tumors
Intervention: Drug: intravenous injection of 177Lu-octreotate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years